| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1050-1738(01)00066-4 |
| P698 | PubMed publication ID | 11343970 |
| P2093 | author name string | Kishimoto T | |
| Yamauchi-Takihara K | |||
| P433 | issue | 7 | |
| P304 | page(s) | 298-303 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Trends in Cardiovascular Medicine | Q1850265 |
| P1476 | title | A novel role for STAT3 in cardiac remodeling | |
| P478 | volume | 10 |
| Q35056026 | Emerging therapeutic targets in chronic heart failure: part II. |
| Q37412473 | Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity. |
| Q41222591 | IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor |
| Q44382975 | Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart. |
| Q28213257 | Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling |
| Q38296419 | Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. |
| Q38345676 | Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism |
| Q90167979 | Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis |
| Q34584027 | Mixed signals in heart failure: cancer rules |
| Q47745076 | Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation |
| Q28580541 | Presenilins in the heart: presenilin-2 expression is increased by low glucose and by hypoxia in cardiac cells |
| Q38100223 | Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy. |
| Q36497007 | Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects |
| Q36895471 | Roles of STATs signaling in cardiovascular diseases |
| Q37734934 | STAT3 and cardiac remodeling |
| Q90362748 | STAT3 for Cardiac Regenerative Medicine: Involvement in Stem Cell Biology, Pathophysiology, and Bioengineering |
| Q38140894 | STAT3 signaling in pulmonary arterial hypertension |
| Q42689024 | Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload |
| Q38334938 | Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein |
| Q39947052 | Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways |
| Q36767218 | The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar |
| Q44132497 | The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes |
| Q94601213 | The effect of HMGA1 in LPS-induced Myocardial Inflammation |
| Q46553059 | The gp130/STAT3 signaling pathway mediates beta-adrenergic receptor-induced atrial natriuretic factor expression in cardiomyocytes |
| Q38790211 | Understanding STAT3 signaling in cardiac ischemia. |
| Q37608600 | gp130-mediated pathway and heart failure |
Search more.